Cargando…

Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells

Lung cancer is the leading cause of cancer death worldwide. There is an urgent need for early diagnostic tools and novel therapies in order to increase lung cancer survival. Secretory phospholipase A2 group IIa (sPLA2-IIa) is involved in inflammation, tumorigenesis and metastasis. We were the first...

Descripción completa

Detalles Bibliográficos
Autores principales:	DONG, ZHONGYUN, MELLER, JAROSLAW, SUCCOP, PAUL, WANG, JIANG, WIKENHEISER-BROKAMP, KATHRYN, STARNES, SANDRA, LU, SHAN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2014
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121404/ https://www.ncbi.nlm.nih.gov/pubmed/24913497 http://dx.doi.org/10.3892/ijo.2014.2486

Ejemplares similares

Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules
por: Kupert, Elena, et al.
Publicado: (2011)

Secretory Phospholipase A(2)-IIA and Cardiovascular Disease: A Mendelian Randomization Study
por: Holmes, Michael V., et al.
Publicado: (2013)

HER2 inhibition increases non-muscle myosin IIA to promote tumorigenesis in HER2+ breast cancers
por: Alanazi, Samar M., et al.
Publicado: (2023)

Sinapicacid Inhibits Group IIA Secretory Phospholipase A(2) and Its Inflammatory Response in Mice
por: Giresha, Aladahalli S., et al.
Publicado: (2022)

Effect of polyunsaturated fatty acids on secretory phospholipase A2 type IIa in ectopic endometrial cells
por: Khanaki, Korosh, et al.
Publicado: (2012)

Functional Analysis of Two PLA2G2A Variants Associated with Secretory Phospholipase A2-IIA Levels
por: Exeter, Holly J., et al.
Publicado: (2012)

The role of group IIA secretory phospholipase A2 (sPLA2-IIA) as a biomarker for the diagnosis of sepsis and bacterial infection in adults—A systematic review
por: Tan, Toh Leong, et al.
Publicado: (2017)

Discrete Role for Cytosolic Phospholipase A(2)α in Platelets: Studies Using Single and Double Mutant Mice of Cytosolic and Group IIA Secretory Phospholipase A(2)
por: Wong, Dennis A., et al.
Publicado: (2002)

Group IIA secretory phospholipase 2 independently predicts mortality and positive blood culture in emergency department sepsis patients
por: Nandi, Utsav, et al.
Publicado: (2021)

Mucoepidermoid Carcinoma of the Lung: A Case Report and Literature Review
por: Alsidawi, S., et al.
Publicado: (2013)

Secretory Phospholipases A(2) in Plants
por: Mariani, María Elisa, et al.
Publicado: (2019)

Biology of Secretory Phospholipase A(2)
por: Boyanovsky, Boris B., et al.
Publicado: (2008)

The secretory phospholipase A(2) group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?
por: Divchev, Dimitar, et al.
Publicado: (2008)

AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs
por: El Hadri, Khadija, et al.
Publicado: (2015)

An Amperometric Biosensor for the Determination of Bacterial Sepsis Biomarker, Secretory Phospholipase Group 2-IIA Using a Tri-Enzyme System
por: Nik Mansor, Nik Nurhanan, et al.
Publicado: (2018)

Measurement of a Novel Biomarker, Secretory Phospholipase A2 Group IIA as a Marker of Sepsis: A Pilot Study
por: Berg, Elena, et al.
Publicado: (2018)

Posttranscriptional upregulation of HER3 by HER2 mRNA induces trastuzumab resistance in breast cancer
por: Li, Xin, et al.
Publicado: (2018)

Group IIA Secretory Phospholipase A(2) Predicts Graft Failure and Mortality in Renal Transplant Recipients by Mediating Decreased Kidney Function
por: Annema, Wijtske, et al.
Publicado: (2020)

Secretory Phospholipase A(2) Enzymes in Acute Lung Injury
por: Letsiou, Eleftheria, et al.
Publicado: (2021)

The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
por: Majumder, Avisek, et al.
Publicado: (2021)

HER kinase inhibition in patients with HER2- and HER3-mutant cancers
por: Hyman, David M., et al.
Publicado: (2018)

CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department
por: Tan, Toh Leong, et al.
Publicado: (2016)

Secretory Phospholipase A2s in Insulin Resistance and Metabolism
por: Kuefner, Michael S.
Publicado: (2021)

Progranulin inhibits phospholipase sPLA2-IIA to control neuroinflammation
por: Du, Huan, et al.
Publicado: (2023)

Effect of VH–VL Families in Pertuzumab and Trastuzumab Recombinant Production, Her2 and FcγIIA Binding
por: Ling, Wei-Li, et al.
Publicado: (2018)

Cytogenetic analysis of HER1/EGFR, HER2, HER3 and HER4 in 278 breast cancer patients
por: Sassen, Andrea, et al.
Publicado: (2008)

The impact of HER2-directed targeted therapy on HER2-positive DCIS of the breast
por: Lewis, Gary. D., et al.
Publicado: (2021)

HER3, p95HER2, and HER2 protein expression levels define multiple subtypes of HER2-positive metastatic breast cancer
por: Lipton, Allan, et al.
Publicado: (2013)

Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
por: Horimoto, Yoshiya, et al.
Publicado: (2022)

Preclinical HER-2 Vaccines: From Rodent to Human HER-2
por: Lollini, Pier-Luigi, et al.
Publicado: (2013)

HER2 signaling regulates HER2 localization and membrane retention
por: Jeong, Jaekwang, et al.
Publicado: (2017)

Inhibition of Group IIA Secretory Phospholipase A(2) and its Inflammatory Reactions in Mice by Ethanolic Extract of Andrographis paniculata, a Well-known Medicinal Food
por: Kishore, V., et al.
Publicado: (2016)

Secretory phospholipase A(2)-IIA overexpressing mice exhibit cyclic alopecia mediated through aberrant hair shaft differentiation and impaired wound healing response
por: Chovatiya, Gopal L., et al.
Publicado: (2017)

Corosolic Acid Inhibits Secretory Phospholipase A(2)IIa as an Anti-Inflammatory Function and Exhibits Anti-Tumor Activity in Ehrlich Ascites Carcinoma Bearing Mice
por: Pundalik, Sophiya, et al.
Publicado: (2022)

Correlation of HER2, p95HER2 and HER3 Expression and Treatment Outcome of Lapatinib plus Capecitabine in her2-Positive Metastatic Breast Cancer
por: Han, Sae-Won, et al.
Publicado: (2012)

Role of secretory phospholipase A(2) in women with metabolic syndrome
por: Pop, D., et al.
Publicado: (2013)

Secretory phospholipase A2 in the pathogenesis of acute dengue infection
por: Jeewandara, Chandima, et al.
Publicado: (2016)

Multimodal regulation of the osteoclastogenesis process by secreted group IIA phospholipase A(2)
por: Mangini, Maria, et al.
Publicado: (2022)

Frequent Upregulation Of HER2 Protein In Hormone Receptor-Positive HER2-Negative Breast Cancer After Short-Term Neoadjuvant Endocrine Therapy
por: Chaudhary, Lubna Naaz, et al.
Publicado: (2023)

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancer
por: Stenehjem, David D, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_40b5bi0e8bnn2qmd5grp9mqi9e